AR · State regulatory reference
Arkansas.
Moderate
Arkansas requires a professional relationship before telemedicine treatment under the Telemedicine Act (Ark. Code § 17-80-401 et seq.) and Arkansas State Medical Board Rule 2.8: a new patient relationship may be formed via real-time audio-and-visual technology (an online questionnaire, audio-only, email, text, or fax alone are insufficient), after which prescribing of non-controlled drugs is permitted. This audio-plus-visual requirement is a standard-of-care provision similar to other states rather than a peptide-specific restriction. Compounding follows USP <795>/<797> with no distinctive state GLP-1 rule, and no Arkansas-specific peptide/GLP-1 enforcement was found.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Under Ark. Code § 17-80-402/403 and ASMB Rule 2.8, an initial visit and prescribing can occur via synchronous audio-video, but a new relationship cannot be formed by audio-only/telephone, questionnaire, email, text, or fax alone; controlled substances via telemedicine remain restricted.
Compounding
The Arkansas Board of Pharmacy regulates 503A compounding consistent with USP <795>/<797> standards, with no distinctive state-specific GLP-1/semaglutide restriction identified; 2025 legislation addressed 503B-to-503A sourcing rather than adding restrictions.
Sources